Schedule 13G ownership disclosure

Celldex Therapeutics Inc

Security class unavailable · CUSIP: 15117B202

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,700,000
Percent of class
4.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000935836-20-000571
Form type
SC 13G
Filer
Celldex Therapeutics, Inc.
CIK
CIK 744218
Filed
Oct 22, 2020
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub